Sunshine Biopharma Inc.
SBFMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.57K in total; no superinvestor holds it.
Other share classesSBFM
Q2 2022 vs. Q1 2022
How the institutions holding Sunshine Biopharma Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 6 | 4 | −2 |
| Shares | 1.27M | 72.5K | −1.20M (−94.3%) |
| Value | $1.26M | $49.0K | −$1.21M (−96.1%) |
New holders (2)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 46,857 | $38.0K | 0.00% |
| Bank of America Corp | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 884,600 | $876.0K |
| CVI Holdings, LLC | 74,632 | $74.0K |
| Hudson Bay Capital Management LP | 60,000 | $59.0K |
| Clear Street LLC | 14,126 | $14.0K |